Nexiva Infusion Device Stopcock May Leak During Treatment
Becton Dickinson is recalling Nexiva infusion devices with pink stopcock components due to potential leakage at the housing that could interrupt treatment or expose patients to infusate and biohazardous material.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a medical device with potential for serious patient harm, including treatment interruption and exposure to biohazardous material. No illnesses or injuries have been reported to date, which per the rubric limits the score to 3 (High) rather than 4 (Severe).
Plain-English summary
Becton Dickinson & Company is recalling approximately 40,050 Nexiva infusion devices with Single BD Connecta Stopcock Version (Pink, Catalog No. 383687) due to a potential leakage hazard at the housing component of the stopcock.
The leakage may result in interruption or delay of treatment, exposure to infusate (the fluid being infused) and biohazardous material, under-dosing or under-infusion, contamination, and air ingress into the infusion line. These devices are used in hospitals and healthcare settings for intravenous therapy and medication delivery.
The affected devices were distributed worldwide, including throughout the United States. Specific lot numbers with expiration dates ranging from March 31, 2024 through July 31, 2024 are involved. Healthcare facilities that have received affected devices should stop use and contact Becton Dickinson & Company for instructions on replacement or return.
Patients or healthcare providers with questions about affected devices should contact Becton Dickinson & Company with the recall information provided.
The recalled product
- Product
- Nexiva with Single BD Connecta Stopcock Version (Pink) Catalog No. 383687 (OUS)
- Manufacturer
- Becton Dickinson & Company
- Hazard
- leakage
- treatment-interruption
- biohazard-exposure
- under-dosing
- air-ingress
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- SevereMedline Spinal Block Kits Recalled for Data Integrity and Efficacy Issues
FDA (Devices) · 2026-06-03
- SevereAbiomed Automated Impella Controller recalled for motor control and pump failure risks
FDA (Devices) · 2026-06-03
- HighGE APEXPRO and CARESCAPE Telemetry Systems Risk Loss of Patient Monitoring
FDA (Devices) · 2026-06-03
- CriticalMedline spinal anesthetic kits recalled for quality and efficacy concerns
FDA (Devices) · 2026-06-03
- SevereMedline spinal anesthesia kits recalled for bupivacaine quality issues
FDA (Devices) · 2026-06-03